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Ischemic Stroke in Patients With Intracranial 
Dural Arteriovenous Fistulas
Shin-Joe Yeh,1 Li-Kai Tsai,2 Hon-Man Liu,3 Ping-Keung Yip,4 Jiann-Shing Jeng2*
Background/Purpose: Intracranial dural arteriovenous fistulas (DAVFs) can be complicated by ischemic
stroke. This study investigated the frequency and determinants of ischemic stroke in patients with intracra-
nial DAVF.
Methods: We conducted a retrospective study of consecutive patients with intracranial DAVF. Patients with
pure hemorrhagic stroke or without available brain imaging for clarifying stroke type were excluded. 
DAVF was diagnosed by cerebral catheter angiography. Cognard classification and location of DAVFs were
ascertained. The clinical characteristics, outcome, and radiographic findings were recorded. Factors associ-
ated with occurrence of ischemic stroke in the patients with DAVFs were determined.
Results: A total of 134 patients were enrolled. Six patients (4.5%) had ischemic stroke (mean age:
53.8 ± 13.4 years) and 128 patients were free from stroke (mean age: 55.4 ± 15.2 years). Men accounted for
83% in the ischemic stroke group and 34% in the non-stroke group. Chemosis, exophthalmos and tinni-
tus were more frequent in the non-stroke group, whereas seizure and mental decline were more frequent
in the ischemic stroke group. DAVF was associated with highest risk of ischemic stroke at locations other
than the cavernous sinus or large sinuses. Ischemic stroke also correlated with types of DAVF involving
cortical venous drainage, including type IIb (18%), III (15%), and IV (100%). No patient with DAVF type
I and IIa had ischemic stroke. The rate of ischemic stroke in patients with concomitant DAVF and cerebral
sinus thrombosis was higher than in DAVF patients without cerebral sinus thrombosis. Venous infarct was
the major subtype of ischemic stroke in five DAVF patients. Endovascular therapy was the most common
choice in both groups, and fewer patients in the ischemic stroke group did not receive any treatment for
DAVFs.
Conclusion: Location and type of DAVF were two important factors related to the occurrence of ischemic
stroke in DAVF patients.
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Intracranial dural arteriovenous fistulas (DAVFs)
are abnormal arteriovenous shunts between
dural arterial feeders and dural venous drainage
channels. DAVFs comprise 10–15% of all in-
tracranial vascular malformations.1–3 The clinical
presentation of DAVF is highly variable, and 
includes pulsatile tinnitus, chemosis of the eyes,
exophthalmos, double vision, seizure, cognitive
decline, and stroke.2,4,5 These manifestations are
usually related to the location and drainage pat-
tern of the DAVF.4,6 Stroke is an uncommon but
severe manifestation. There have been many arti-
cles that have discussed the frequency and deter-
minants of intracranial hemorrhage associated
with DAVF,1,2,4–10 but there have been no large
case series to delineate the relationship between
ischemic stroke and intracranial DAVF. Prompt
and adequate treatment of DAVF patients at high
risk for ischemic stroke might prevent stroke.
Also, effective treatment of DAVFs in stroke pa-
tients can prevent stroke recurrence. Therefore,
identification and treatment of high-risk DAVF
patients might offer clinical benefit. The aims of
this study were to assess the frequency, predic-
tors, and neuroimaging characteristics of DAVF-
related ischemic stroke.
Materials and Methods
A total of 158 consecutive patients diagnosed
with DAVF and admitted to the National Taiwan
University Hospital, Taipei, Taiwan, from January
1995 to December 2007 were retrospectively 
reviewed. The diagnosis of DAVF in each patient
was based on cerebral catheter angiography. Four
patients who developed stroke after endovascular
treatment for DAVF were excluded.
The medical records of each patient were re-
viewed by two of the authors (S.J Yeh and L.K. Tsai)
and the data were abstracted systematically. The
details of clinical and radiological manifesta-
tions, risk factors, and outcome were recorded.
Angiographic findings were reviewed for the loca-
tion, drainage pattern, and possible cerebral sinus
thrombosis (CST) of DAVFs. The angiographic
features of CST were defined as abrupt cessation
and stasis of contrast medium.6
The drainage patterns of DAVFs were classified
according to the Cognard classification method
as follows: type I, located in the main sinus with-
out reflux; type II, located in the main sinus with
reflux into the sinus (IIa), cortical veins (IIb), or
both (IIa + b); type III, with direct cortical venous
drainage without venous ectasia; type IV, with di-
rect cortical venous drainage with venous ectasia;
and type V, with spinal venous drainage.8 The lo-
cations of DAVFs were divided into three groups,
as previously reported,11 including cavernous
sinus (Figure 1), large cerebral sinus (Figure 2),
and other locations. Large sinuses included trans-
verse, sigmoid, and superior sagittal sinuses. The
drainage sites of DAVFs other than large sinuses
and cavernous sinuses were defined as other loca-
tions. In cavernous sinus DAVF, direct carotid–
cavernous fistula was excluded because it is not a
transdural fistula.4
The diagnosis of ischemic stroke was based on
clinical manifestation and neuroimaging find-
ings. Acute stroke was defined as acute onset of a
focal neurological deficit that persisted for > 24
hours. The diagnosis of acute ischemic stroke 
requires diffusion restriction on brain magnetic
resonance imaging (MRI). Venous infarct is a
special kind of infarct other than arterial infarct
in patients with DAVF. The definition of venous
infarct on brain MRI is based on hypointensity
on apparent diffusion coefficient (ADC) map-
ping, and the infarct region not corresponding to
an arterial territory.11 Hyperintensity on diffusion-
weighted imaging without decrease of ADC value
is consistent with T2 shine-through effect, which
can be attributed to vasogenic edema instead of
venous infarct.11 Follow-up brain images were
also reviewed for negative mass effect at the in-
farct region. Infarct with hemorrhagic transfor-
mation was included in the ischemic stroke group.
Seizure with Todd’s paralysis was excluded from
stroke by clinical manifestations of seizure.
Student t test for age and Fisher exact test for
categorical variables were used to assess the statis-
tical difference between the ischemic stroke and
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non-stroke groups. Multiple logistic regression
analysis was not performed due to the very small
sample size of ischemic stroke patients. Results
were considered significant if the p value was
< 0.05. The SPSS 12.0 software package (SPSS,
Chicago, IL, USA) was used for statistical analyses.
Results
Clinical characteristics of DAVF patients with
or without ischemic stroke
Among the 154 patients, 19 (12.3%) who had
pure hemorrhagic stroke were excluded from
A B
Figure 1. Type I dural arteriovenous fistulas (black arrows) at the left cavernous sinus with drainage to bilateral superior
ophthalmic veins. Angiography of the left external carotid artery injection showed early opacification of the left and right
cavernous sinuses through the intercavernous communication (A), with subsequent drainage into bilateral superior 
ophthalmic veins (B).
A B
Figure 2. Type IIa + b dural arteriovenous fistulas at the left transverse sigmoid sinus. The anterior–posterior (A) and 
lateral (B) views of angiography from the left external carotid artery injection showed dural arteriovenous fistulas (black
arrows) at the left transverse sigmoid sinus, supplied by multiple feeding arteries from the left external carotid artery,
with retrograde drainage to many tortuous cortical veins and right transverse sinus.
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analysis because this study focused on ischemic
stroke. The brain MRI film of another patient
was not available for clarifying stroke subtype,
therefore, that patient was not enrolled into the
analysis. The remaining 134 patients were di-
vided into two groups: with ischemic stroke and
without stroke. Of the 134 patients, the average
age was 55.3 ± 15.1 years, and 85 (63.4%) were
female. Six patients had ischemic stroke (mean
age: 53.8 ± 13.4 years). The clinical characteris-
tics are listed in Table 1. In the group of patients
with ischemic stroke, male patients accounted
for 83.3%. On the contrary, in the group without
stroke, only 34.4% of patients were male. No pa-
tient in the ischemic stroke group presented with
tinnitus, eye chemosis, or exophthalmos, whereas
in the non-stroke group, a considerable number
of patients presented with these symptoms (54%,
40%, and 36%, respectively). Seizure (6% vs. 33%,
p = 0.052) and cognitive decline (3% vs. 17%, p =
0.208) were more frequent in patients with is-
chemic stroke, but without statistical significance.
There were no significant differences in the fre-
quency of headache or change in consciousness
between the two groups.
The type of DAVF also was found to influence
the risk of ischemic stroke (Table 2). There was
no ischemic stroke in patients with type I and
type IIa DAVF. Ischemic stroke occurred in pa-
tients with type IIb (18%), III (15%), and IV
(100%) DAVF. Comparison of the occurrence of
ischemic stroke in DAVFs without cortical venous
drainage (type I and IIa) and with cortical venous
drainage (type IIb, IIa + b, III, IV, and V) showed
that there was a significant difference between
the two groups (0% vs. 12%, p = 0.003).
With regard to location of DAVF (Table 2),
patients with cavernous sinus DAVF had no 
ischemic stroke; this contrasted with moderate
frequency of ischemic stroke in patients with
DAVF in large sinuses (2%, p = 0.665), and signif-
icantly higher frequency of ischemic stroke in
patients with DAVF in other locations (16%,
p = 0.003).
Imaging findings of DAVF-related ischemic
stroke
Among the six patients with infarction, five had
findings that were compatible with venous in-
farction on brain imaging. The infarct region in
the final patient with ischemic stroke was at the
basal ganglia and might have been an arterial in-
farction. The most characteristic imaging finding
of venous infarction was hypointensity on the ADC
map of MRI, which indicated cytotoxic edema.
The infarct region also did not follow an arterial
territory. Other associated features included ab-
normal vascular enhancement, infarct with pe-
techial hemorrhage, and vasogenic edema. Four
of the infarction patients had CST. Patients with
CST had higher risk of ischemic stroke than those
without (10% vs. 3%, p = 0.136).
Table 1. Clinical characteristics of dural arteriovenous fistula patients with or without ischemic strokea
Without stroke (n = 128) With IS (n = 6) p
Age (yr) 55.4 ± 15.2 53.8 ± 13.4 0.811
Male sex 44 (34) 5 (83) 0.025
Clinical presentations
Tinnitus 69 (54) 0 (0) 0.012
Exophthalmos 46 (36) 0 (0) 0.095
Chemosis 51 (40) 0 (0) 0.044
Headache 32 (25) 1 (17) 1.000
Conscious changes 1 (1) 0 (0) 1.000
Seizure 7 (6) 2 (33) 0.052
Cognitive decline 4 (3) 1 (17) 0.208
aData are presented as mean ± standard deviation or n (%). IS = ischemic stroke.
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Treatment and outcome
The treatment modalities in these patients are
listed in Table 3. The most frequently used treat-
ment for DAVF in this series was endovascular
treatment, which was used in 66.4% of patients
in the non-stroke group and 66.7% in the is-
chemic stroke group. One patient in the ischemic
stroke group and four in the non-stroke group
were treated with gamma knife therapy. Surgical
procedures were performed in one non-stroke
patient, but none were performed in ischemic
stroke patients. There was no interventional treat-
ment in 30% of patients in the non-stroke group
and 17% in the ischemic stroke group (p = 0.67).
Of the six ischemic stroke patients with DAVF,
three had a good functional outcome (modified
Rankin scale 0 or 1), and three had an unfavor-
able outcome (modified Rankin scale ≥ 2). The
outcome was not significantly related to cerebral
venous thrombosis, or DAVF type, location or
treatment.
Discussion
This was a retrospective study to examine the fac-
tors related to occurrence of ischemic stroke in
DAVF patients. This was the first study to focus
Table 3. Treatment modalities between the two groups of dural arteriovenous fistula patients with and
without ischemic strokea
Without stroke (n = 128) With IS (n = 6) p
Endovascular therapy 85 (66) 4 (67) 1.000
Operation 1 (1) 0 (0) 1.000
Gamma-knife 4 (3) 1 (17) 0.208
Without treatment of DAVF 38 (30) 1 (17) 0.671
aData are presented as n (%). IS = ischemic stroke; DAVF = dural arteriovenous fistula.
Table 2. Angiographic characters of dural arteriovenous fistulas in the two groups with and without ischemic
strokea
Without stroke (n = 128) With IS (n = 6) p
Type of DAVF
I 58 (45) 0 (0) 0.036
IIa 24 (19) 0 (0) 0.591
IIb 9 (7) 2 (33) 0.077
IIa + b 18 (14) 0 (0) 1.000
III 17 (13) 3 (50) 0.043
IV 0 (0) 1 (17) 0.045
V 2 (2) 0 (0) 1.000
Type of DAVF (grouping)
I + IIa 82 (64) 0 (0) 0.003
IIb + IIa + b + III + IV + V 46 (36) 6 (100)
Location of DAVF
Cavernous sinus 56 (44) 0 (0) 0.04
Large sinusesb 46 (36) 1 (17) 0.665
Other locationsc 26 (20) 5 (83) 0.003
CST
With CST 28 (22) 3 (9.7) 0.136
Without CST 100 (78) 3 (2.9)
aData are presented as n (%); btransverse sinus, sigmoid sinus, and superior sagittal sinus; call locations other than cavernous sinus
and large sinuses. IS = ischemic stroke; DAVF = dural arteriovenous fistula; CST = cerebral sinus thrombosis.
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on ischemic stroke in DAVF patients. Our major
findings were that DAVF types that involved corti-
cal venous drainage and DAVFs at other locations
had a significant influence on the occurrence of
ischemic stroke in DAVF patients.
DAVFs at other locations are associated with
intracranial hemorrhage or aggressive manifesta-
tions,4,6,10 and it also correlated with occurrence
of ischemic stroke in our study. DAVFs at large 
sinuses were associated with less risk of ischemic
stroke than at other locations. The venous out-
flow capacity of DAVFs at large sinuses was larger
than at other locations, and venous stagnation
was the major mechanism of DAVF-related is-
chemic stroke.12 The venous stagnation in DAVFs
at large sinuses is less severe than that at other lo-
cations, so DAVFs at large sinuses are associated
with less risk of ischemic stroke. However, patients
with large sinus DAVF were not free from ischemic
stroke, which might be because of rare sponta-
neous regression and high flow.13 Cavernous
sinus DAVF is known to have the most benign
course.1,6,13,14 In the present study, patients with
exophthalmos or eye chemosis were all shown to
have cavernous sinus DAVF and they were all free
from ischemic stroke. The reasons for this might
be early detection of DAVF by eye symptoms, be-
nign venous drainage pattern, and higher percent-
age of spontaneous regression.13
Type of DAVF is an independent predictor of
aggressive manifestations,4,6,8,9 and it also played
an independent role in the occurrence of ischemic
stroke in our study. It was particularly interesting
that the rate of ischemic stroke in type IIa+b DAVF
was lower than that in type IIb. Partial venous 
reflux into a large sinus in type IIa + b might have
contributed to relieving some of the venous pres-
sure, therefore, the rate of ischemic stroke was
lower than in type IIb. The rate of ischemic stroke
in type IV was much higher than in type III,
which further confirmed the dangerous sign of
venous ectasia.15
CST was also a borderline predictor of ischemic
stroke in DAVF patients, which is compatible with
the previous study of Tsai et al.6 CST can result in
venous hypertension and infarction.16 CST and
DAVF are considered to have a causal relationship
with each other.14 CST could result in opening of
dural arteriovenous shunts, which might become
DAVFs. In addition, the abnormal high flow of
DAVF might damage the venous wall, which could
result in CST.
Male sex is known to be a risk factor for ag-
gressive manifestation in DAVF patients.6 In the
present study, there was also a significant trend
that male DAVF patients were more susceptible
to ischemic stroke than their female counterparts.
This partly reflected the different location distri-
bution of DAVF: 49% of DAVFs in female pa-
tients and 29% in male patients were located at the
cavernous sinus, which was associated with the
lowest risk of ischemic stroke.
The imaging characteristics of ischemic stroke
in patients with DAVF differed from those in pa-
tients with arterial stroke. In this study, five of
the six infarct patients had venous infarction that
was secondary to venous hypertension. Venous
hypertension decreases cerebral blood flow, which
causes tissue damage and cytotoxic edema.11,12
This presents as hypointensity on ADC maps and
is defined as venous infarct. The rising venous
pressure also disrupts the blood–brain barrier,
which increases net capillary filtration and leads
to the development of vasogenic edema.11 In the
single patient with infarct at the basal ganglia,
infarction might have been secondary to his hy-
pertension, which resulted in arterial thrombosis.
This suggests that intracranial DAVF should be
considered as an important differential diagnosis
in patients with ischemic stroke and imaging
findings compatible with venous infarct. For sus-
pected cases, carotid duplex study is a valid modal-
ity before performing angiography to check for
the possibility of DAVF by a decreased resistivity
index of the external carotid artery < 0.72.17
The main treatment modality in this series was
endovascular treatment, which is less invasive than
traditional surgery. The ratios of patients without
interventional treatment did not differ signifi-
cantly between the ischemic stroke and non-stroke
groups. In the ischemic stroke group, the only
patient who did not receive treatment for DAVFs
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had arterial stroke rather than venous infarct. In
other words, all of the DAVF patients with venous
infarct received treatment for DAVFs. As for the ra-
tios of favorable outcome, there was no significant
difference between the non-stroke and ischemic
stroke groups, which indicated that the initial pres-
entation of non-stroke symptoms might not be a
guarantee of a good outcome in DAVF patients.
There were some limitations in our study.
First, although, to the best of our knowledge, this
was the largest case series to date, the number of
patients was still small, which might have af-
fected the statistical power of the study. Second,
this was a hospital-based study, therefore, some
asymptomatic DAVF patients might not have been
included. However, the diagnosis of DAVF depends
on angiography, therefore, it is impossible to screen
for DAVF in the general population. Third, this
study was retrospective, and the symptoms were
only obtained from medical records, which might
have been underestimated if patients did not 
report their symptoms. However, in our hospital,
patients who were suspected or confirmed to have
DAVF were routinely asked about symptoms of
DAVF. Therefore, the possibility of underestima-
tion could have been low.
In conclusion, our study showed that the risk
of ischemic stroke in DAVF patients is associated
with the location and type of DAVF. When pa-
tients present with ischemic stroke with imaging
characteristics of venous infarct, the possibility of
DAVF should not be neglected. Conventional an-
giography is mandatory for these patients because
DAVF is a treatable etiology of stroke.
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